Abbott and Dexcom outpaced Medtronic's diabetes business last year
Diabetes sales in 2022, by company or segment.
Abbott and Dexcom had the highest diabetes sales, at $4.76 billion and $2.91 billion, respectively. Medtronic was third with sales of $2.34 billion.
